These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30292735)

  • 21. Investigating the molecular mechanisms underlying the co-occurrence of Parkinson's disease and inflammatory bowel disease through the integration of multiple datasets.
    Sun Q; Li YJ; Ning SB
    Sci Rep; 2024 Jul; 14(1):17028. PubMed ID: 39043798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention.
    Aleksandrova K; Romero-Mosquera B; Hernandez V
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28867793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease.
    Schwiertz A; Spiegel J; Dillmann U; Grundmann D; Bürmann J; Faßbender K; Schäfer KH; Unger MM
    Parkinsonism Relat Disord; 2018 May; 50():104-107. PubMed ID: 29454662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbial treatment: the potential application for Parkinson's disease.
    Fang X
    Neurol Sci; 2019 Jan; 40(1):51-58. PubMed ID: 30415447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut bacterial composition in a mouse model of Parkinson's disease.
    Perez-Pardo P; Dodiya HB; Engen PA; Naqib A; Forsyth CB; Green SJ; Garssen J; Keshavarzian A; Kraneveld AD
    Benef Microbes; 2018 Sep; 9(5):799-814. PubMed ID: 30099890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interplay between microbes and the immune response in inflammatory bowel disease.
    Goethel A; Croitoru K; Philpott DJ
    J Physiol; 2018 Sep; 596(17):3869-3882. PubMed ID: 29806140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease.
    Chiang HL; Lin CH
    J Mov Disord; 2019 May; 12(2):67-83. PubMed ID: 31158941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of immune-driven pathogenesis in Parkinson's disease by gut microbiota.
    Zheng W; He R; Yan Z; Huang Y; Huang W; Cai Z; Su Y; Liu S; Deng Y; Wang Q; Xie H
    Brain Behav Immun; 2020 Jul; 87():890-897. PubMed ID: 31931152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controversy on the role of short-chain fatty acids in the pathogenesis of Parkinson's disease.
    Mulak A
    Mov Disord; 2018 Mar; 33(3):398-401. PubMed ID: 29436731
    [No Abstract]   [Full Text] [Related]  

  • 30. Gut feelings about smoking and coffee in Parkinson's disease.
    Derkinderen P; Shannon KM; Brundin P
    Mov Disord; 2014 Jul; 29(8):976-9. PubMed ID: 24753353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: Relevance to idiopathic Parkinson's disease.
    Ilieva NM; Wallen ZD; De Miranda BR
    Toxicol Appl Pharmacol; 2022 Sep; 451():116176. PubMed ID: 35914559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Intestinal Microbiota in Inflammatory Bowel Disease.
    Becker C; Neurath MF; Wirtz S
    ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Gut and Nonmotor Symptoms in Parkinson's Disease.
    Klingelhoefer L; Reichmann H
    Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms.
    Xie A; Ensink E; Li P; Gordevičius J; Marshall LL; George S; Pospisilik JA; Aho VTE; Houser MC; Pereira PAB; Rudi K; Paulin L; Tansey MG; Auvinen P; Brundin P; Brundin L; Labrie V; Scheperjans F
    Mov Disord; 2022 Aug; 37(8):1644-1653. PubMed ID: 35723531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease.
    Hegelmaier T; Lebbing M; Duscha A; Tomaske L; Tönges L; Holm JB; Bjørn Nielsen H; Gatermann SG; Przuntek H; Haghikia A
    Cells; 2020 Feb; 9(2):. PubMed ID: 32041265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired Autophagy in Intestinal Epithelial Cells Alters Gut Microbiota and Host Immune Responses.
    Yang L; Liu C; Zhao W; He C; Ding J; Dai R; Xu K; Xiao L; Luo L; Liu S; Li W; Meng H
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut microbiome-based secondary metabolite biosynthetic gene clusters detection in Parkinson's disease.
    Wang S; Li N; Zou H; Wu M
    Neurosci Lett; 2019 Mar; 696():93-98. PubMed ID: 30572101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.